Shin JE

No ORCID on file · 7 papers in corpus
2025
International journal of molecular sciences ·doi:10.3390/ijms26146585

Recurrent pregnancy loss (RPL) is defined as the occurrence of two or more consecutive pregnancy losses before 20 weeks of gestation, encompassing both embryonic and fetal losses. Although previous studies have provided substantial insights…

2024
Antioxidants (Basel, Switzerland) ·doi:10.3390/antiox13030321

(1) Background: Oxidative stress adversely affects fertility by impairing oocyte fertilization potential, primarily due to meiotic segregation errors and cohesion loss. Superoxide dismutase (SOD) and Coenzyme Q10 (CoQ10) are prominent antio…

2023
Biomedicines ·doi:10.3390/biomedicines11051374

Recurrent implantation failure (RIF) refers to two or more unsuccessful in vitro fertilization embryo transfers in the same individual. Embryonic characteristics, immunological factors, and coagulation factors are known to be the causes of …

article 2020
Obstetrics & gynecology science ·doi:10.5468/ogs.2020.63.3.357

OBJECTIVE: To evaluate the clinical and pathological characteristics of lower anterior abdominal wall masses suspicious for endometriosis. METHODS: A retrospective review of 38 patients who underwent surgery for a lower anterior abdominal w…

2019
Annals of laboratory medicine ·doi:10.3343/alm.2019.39.3.252

BackgroundThe risk of ovarian malignancy algorithm (ROMA) is used for assessing ovarian cancer risk in women with a pelvic mass. Its diagnostic accuracy is variable. We investigated whether the clinically acceptable minimal sensitivity of >…

2017
Clinical and experimental reproductive medicine ·doi:10.5653/cerm.2017.44.1.1

The task force of the Korean Society for Reproductive Immunology recommends intravenous immunoglobulin G treatment in women with reproductive failure, including recurrent pregnancy loss and/or repeated implantation failure, who show cellula…

2011
Korean journal of radiology ·doi:10.3348/kjr.2011.12.4.456

ObjectiveWe wanted to evaluate the diagnostic value of serum CA-125 concentration, when used in combination with the preoperative contrast-enhanced CT results, to differentiate borderline ovarian tumors (BOTs) from stage I malignant epithel…